NOTE: The following report appears in both International Trade Today and Export Compliance Daily.
WCO, WHO Issue Updated COVID-19 Medical Supplies Classification Guide
The World Customs Organization, with help from the World Health Organization, updated its list of tariff classifications for COVID-19 medical supplies to include priority medicines, the WCO said in a news release. “The List of WHO/WCO Priority Medicines for Customs…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
Used during COVID-19 aims at assisting Customs and economic operators in classifying these medicines,” it said. The list contains the suggested HS codes for medicines used in the general medical care administered to hospitalized patients; as part of the direct treatment of the COVID-19 disease; and for which interrupted supply could result in serious health consequences. The new list, which will now be continuously updated, is the result of an efficient collaboration between the WHO and the WCO. The medicines and active substances were compiled by the WHO taking into account various information published by National Health Authorities, scientific societies or pharmacology experts, and with suggested HS codes provided by the WCO Secretariat.”